ReviewRSC medicinal chemistry2026

Bridging BET bromodomain and immune checkpoint inhibitors through generative bioorganic frameworks for next-generation cancer immunotherapy.

Mohamed K Diab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.